Pten loss induces autocrine FGF signaling to promote skin tumorigenesis

Cell Reports

Volumn 6, Issue 5, 2014, Pages 818-826

  Hertzler Schaefer, Kristina ^a   Mathew, Grinu ^b   Somani, Ally Khan ^c   Tholpady, Sunil ^c   Kadakia, Madhavi P ^d   Chen, Yiping ^e   Spandau, Dan F ^c   Zhang, Xin ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WRIGHT STATE UNIVERSITY   (United States)

^e Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; MESSENGER RNA; FGF10 PROTEIN, HUMAN; FGF10 PROTEIN, MOUSE; PTEN PROTEIN, HUMAN; PTEN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; EPIDERMIS; KERATINOCYTE; MOUSE; MOUSE MODEL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN PAPILLOMA; TRANSLATION INITIATION; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOSS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; PTEN GENE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL TRANSFORMATION; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 10; HUMANS; MICE; MICE, TRANSGENIC; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TRANSFECTION;

EID: 84895924166     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.01.045     Document Type: Article

References (39)

1. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., Fakhry C., Xie T.X., Zhang J., Wang J., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
2. Ashery-Padan R., Marquardt T., Zhou X., Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev. 2000, 14:2701-2711.
3. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
4. Bentzinger C.F., Romanino K., Cloëtta D., Lin S., Mascarenhas J.B., Oliveri F., Xia J., Casanova E., Costa C.F., Brink M., et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 2008, 8:411-424.
5. Braun S., auf dem Keller U., Steiling H., Werner S. Fibroblast growth factors in epithelial repair and cytoprotection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004, 359:753-757.
6. Chikama T., Liu C.Y., Meij J.T., Hayashi Y., Wang I.J., Yang L., Nishida T., Kao W.W. Excess FGF-7 in corneal epithelium causes corneal intraepithelial neoplasia in young mice and epithelium hyperplasia in adult mice. Am. J. Pathol. 2008, 172:638-649.
7. Darido C., Georgy S.R., Wilanowski T., Dworkin S., Auden A., Zhao Q., Rank G., Srivastava S., Finlay M.J., Papenfuss A.T., et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 2011, 20:635-648.
8. Eng C. PTEN: one gene, many syndromes. Hum. Mutat. 2003, 22:183-198.
9. Greco V., Chen T., Rendl M., Schober M., Pasolli H.A., Stokes N., Dela Cruz-Racelis J., Fuchs E. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell 2009, 4:155-169.
10. Grose R., Fantl V., Werner S., Chioni A.M., Jarosz M., Rudling R., Cross B., Hart I.R., Dickson C. The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development. EMBO J. 2007, 26:1268-1278.
11. Guo L., Yu Q.C., Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 1993, 12:973-986.
12. Hoch R.V., Soriano P. Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development. Development 2006, 133:663-673.
13. Hsieh A.C., Liu Y., Edlind M.P., Ingolia N.T., Janes M.R., Sher A., Shi E.Y., Stumpf C.R., Christensen C., Bonham M.J., et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012, 485:55-61.
14. Itohara S., Mombaerts P., Lafaille J., Iacomini J., Nelson A., Clarke A.R., Hooper M.L., Farr A., Tonegawa S. T cell receptor delta gene mutant mice: independent generation of alpha beta Tcells and programmed rearrangements of gamma delta TCR genes. Cell 1993, 72:337-348.
15. Kang S.A., Pacold M.E., Cervantes C.L., Lim D., Lou H.J., Ottina K., Gray N.S., Turk B.E., Yaffe M.B., Sabatini D.M. mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 2013, 341:1236566.
16. Lesche R., Groszer M., Gao J., Wang Y., Messing A., Sun H., Liu X., Wu H. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 2002, 32:148-149.
17. Logié A., Dunois-Lardé C., Rosty C., Levrel O., Blanche M., Ribeiro A., Gasc J.M., Jorcano J., Werner S., Sastre-Garau X., et al. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum. Mol. Genet. 2005, 14:1153-1160.
18. Lu Z.H., Shvartsman M.B., Lee A.Y., Shao J.M., Murray M.M., Kladney R.D., Fan D., Krajewski S., Chiang G.G., Mills G.B., Arbeit J.M. Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis. Cancer Res. 2010, 70:3287-3298.
19. Miller L.A., Smith A.N., Taketo M.M., Lang R.A. Optic cup and facial patterning defects in ocular ectoderm beta-catenin gain-of-function mice. BMC Dev. Biol. 2006, 6:14.
20. Pan Y., Carbe C., Powers A., Zhang E.E., Esko J.D., Grobe K., Feng G.S., Zhang X. Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 2008, 135:301-310.
21. Pan Y., Carbe C., Powers A., Feng G.S., Zhang X. Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development. Development 2010, 137:1085-1093.
22. Pende M., Um S.H., Mieulet V., Sticker M., Goss V.L., Mestan J., Mueller M., Fumagalli S., Kozma S.C., Thomas G. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol. 2004, 24:3112-3124.
23. Qu X., Carbe C., Tao C., Powers A., Lawrence R., van Kuppevelt T.H., Cardoso W.V., Grobe K., Esko J.D., Zhang X. Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate. J.Biol. Chem. 2011, 286:14435-14444.
24. Ramsey M.R., Wilson C., Ory B., Rothenberg S.M., Faquin W., Mills A.A., Ellisen L.W. FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. J.Clin. Invest. 2013, 123:3525-3538.
25. Ridky T.W., Khavari P.A. Pathways sufficient to induce epidermal carcinogenesis. Cell Cycle 2004, 3:621-624.
26. Segrelles C., Lu J., Hammann B., Santos M., Moral M., Cascallana J.L., Lara M.F., Rho O., Carbajal S., Traag J., et al. Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res. 2007, 67:10879-10888.
27. Song M.S., Salmena L., Pandolfi P.P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 2012, 13:283-296.
28. Song Z., Liu C., Iwata J., Gu S., Suzuki A., Sun C., He W., Shu R., Li L., Chai Y., Chen Y. Mice with Tak1 deficiency in neural crest lineage exhibit cleft palate associated with abnormal tongue development. J.Biol. Chem. 2013, 288:10440-10450.
29. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
30. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., Kryukov G.V., Lawrence M.S., Sougnez C., McKenna A., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
31. Suzuki A., Itami S., Ohishi M., Hamada K., Inoue T., Komazawa N., Senoo H., Sasaki T., Takeda J., Manabe M., et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 2003, 63:674-681.
32. Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012, 485:109-113.
33. Turner N., Grose R. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 2010, 10:116-129.
34. Wang Q., Von T., Bronson R., Ruan M., Mu W., Huang A., Maira S.M., Zhao J.J. Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome. Genes Dev. 2013, 27:1568-1580.
35. Werner S., Smola H., Liao X., Longaker M.T., Krieg T., Hofschneider P.H., Williams L.T. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 1994, 266:819-822.
36. Yang J., Meyer M., Müller A.K., Böhm F., Grose R., Dauwalder T., Verrey F., Kopf M., Partanen J., Bloch W., et al. Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis. J.Cell Biol. 2010, 188:935-952.
37. Yu K., Xu J., Liu Z., Sosic D., Shao J., Olson E.N., Towler D.A., Ornitz D.M. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 2003, 130:3063-3074.
38. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., Ornitz D.M. Receptor specificity of the fibroblast growth factor family.The complete mammalian FGF family. J.Biol. Chem. 2006, 281:15694-15700.
39. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 2011, 12:21-35.